Title |
No. |
Absorbable Suture |
8.4 |
Ageing Population |
6.7 |
Anti-Counterfeiting Packaging |
5.8 |
APJ Abdul Kalam |
8.11 |
Artificial Heart |
8.9 |
Biocompatibility |
7.2 |
Biopolymer Materials |
2.15 |
Blood Bags |
9.15 |
Blood Collection Devices |
9.2 |
Blood-Contacting Devices |
8.8 |
Bone Cement |
9.16 |
Cardiac Guide Wires |
11.5 |
Cardiac stents |
9.26 |
Catheter-Related Infections |
10.2 |
Catheters |
1.2 |
China |
6.3 |
Clean Room |
4.1 |
Combination Product |
1.4 |
Combination Products |
7.6 |
Compensation to Patients |
7.1 |
Conductive Plastic |
2.7 |
Contract Manufacturer |
4.4 |
Cornea |
8.3 |
COVID-19 |
3.6 |
COVID-19 |
3.7 |
Dialysis |
10.3 |
Dialysis Filters |
9.24 |
Distribution Channel For Hospitals |
10.6 |
Drug / Device Combination Products |
6.1 |
Drug-Eluting Stents |
3.3 |
Endotracheal Tubes |
9.3 |
Endotracheal Tubes |
9.20 |
Environment |
11.8 |
Faulty Medical Devices |
9.25 |
FDA Regulations |
7.7 |
Filters |
4.7 |
Frugal Innovations |
8.1 |
Haemodialysis |
9.18 |
Health Technology Assessment |
4.5 |
Health Technology Assessment & Management |
1.6 |
Healthcare Plastics Recycling |
11.2 |
Healthcare Supply Chain |
10.5 |
Healthcare Waste Management |
11.9 |
Hemodialysis Catheter |
9.14 |
Heparin In Medical Devices |
9.13 |
Hospital Waste |
11.6 |
Hospital-Acquired Infections |
2.2 |
Human Factors |
9.10 |
Humanitarian Use |
6.6 |
I.V. Administration |
8.12 |
Implants |
6.2 |
Infections |
9.22 |
Innovation Challenges |
8.13 |
Intelligent Materials |
2.10 |
Intraocular Lenses |
8.7 |
Intravenous Infusion Sets ( IV Set ) |
3.4 |
Kidney Patient Injuries |
9.24 |
Knowledge Management |
8.10 |
Leukocyte Reduction Filters |
4.8 |